KACHING KACHING, Inc. (KCKC.OB) Launches New Website and Ticker Symbol
KACHING KACHING, Inc., the first-of-its-kind online retail chain which transforms licensees into actual storeowners able to deal directly with manufacturers/distributors,…
Blog
Biomoda, Inc. (BMOD.OB) Receives Patent in Mexico
One company this is starting to capture the attention of investors is Biomoda Inc. Located in Albuquerque, New Mexico, Biomoda…
Provectus Pharmaceuticals Inc. (PVCT.OB) Releases Updated Data for Clinical Trials of Melanoma Compound
Provectus Pharmaceuticals Inc., a development-stage biopharmaceutical company engaged in oncology and dermatology, today announced additional positive data from its phase…
Talecris Biotherapeutics (TLCR) to Be Acquired by Spanish Company Grifols
Talecris Biotherapeutics is a US-based biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with…
GigOptix, Inc. (GGOX.OB) Appoints Frank Schneider to Board of Directors
GigOptix Inc., a leading supplier of electronic and electro-optic semiconductor products for fiber-optic communications systems, today announced the appointment of…
ZymoGenetics, Inc. (ZGEN) Initiates Phase 2 Clinical Trial for Hepatitis C Investigational Drug Treatment
ZymoGenetics Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutic proteins for the treatment of human…
Lorus Therapeutics (LRUSF.OB) Explains Preliminary Short Form Prospectus Filing
The bio-pharmaceutical company Lorus Therapeutics filed a preliminary short form in Canada. The short form covers the provinces of Ontario,…
Cyberonics, Inc. (CYBX) Posts Record Sales and Profits
Cyberonics recently announced their 4th quarter and fiscal year results. The medical technology company has been gaining traction with their…
Ecosphere Technologies, Inc. (ESPH.OB) to Deploy Ozonix Systems to the Gulf
Diversified environmental services company, Ecosphere Technologies, Inc. announced Friday that the company will participate in remediation efforts related to the…
Anthera Pharmaceuticals, Inc. (ANTH) Announces Dr. Colin Hislop as Chief Medical Officer
Anthera Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, recently…